| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.07 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.39 | 0.07 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.08 |